A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
Active, not recruiting · NCT04293185 · Registry updated 2024-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 3 | 2024-12-10 | NCT04293185 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genetix Biotherapeutics Inc. | 7 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine/Texas Children's Hospital | Houston | United States | 5 |
| Children's National Hospital | Washington D.C. | United States | 100 |
| Duke University | Durham | United States | 91 |
| Hackensack University Medical Center | Hackensack | United States | 308 |
| Montefiore Medical Center | The Bronx | United States | 198 |
| Tufts Medical Center | Boston | United States | 238 |
| University of Alabama | Birmingham | United States | 25 |
| University of Minnesota | Minneapolis | United States | 325 |
| Virginia Commonwealth University (Vcu) | Richmond | United States | 2 |